The CEO of NRx – the US company in charge of trials of Israel’s BriLife coronavirus vaccine – said NRx is designing a Phase II study of BriLife as a booster to protect against COVID-19 variants. The study will be … Continue reading →

The Brilife vaccine, developed by the Israel Institute for Biological Research, appears to give long-term defense against the coronavirus. The 230 trial volunteers who received the highest dosage of the vaccine were still fully protected six months after vaccination. https://www.timesofisrael.com/tv-high-dose-of-israeli-made-vaccine-appears-to-give-long-lasting-protection/

Israel’s Institute for Biological Research IIBR (see here previously) has stated that it has delivered 1,000 doses of its BriLife coronavirus vaccine to Georgia for starting Phase 2 trials. IIBR’s partner, NRx, will lead the trials, expand patient numbers and … Continue reading →

Israel’s IIBR-developed BriLife vaccine (see here previously – now in Phase 2 testing) has advantages over vaccines such as Pfizer and Moderna. It recognizes the whole of the spike protein and can be easily adjusted to protect against mutations. https://www.youtube.com/watch?v=KJCGLJoqh5o

The Israel Institute for Biological Research (IIBR) (see here previously) has signed an agreement with Israeli-founded NRx Pharmaceuticals. NRx will complete Phase 2 / 3 trials and commercialize IIBR’s “BriLife” COVID vaccine. Clinical trials will be completed in the Ukraine, … Continue reading →

The Israeli-developed BriLife Covid-19 vaccine is moving into Phase 2 trials. Hospitals including Sheba and Hadassah will test the vaccine on 1,000 volunteers including seniors and those with previous conditions. Meanwhile rollout of the Pfizer vaccine began – the Israeli … Continue reading →

The Covid-19 vaccine being developed by the Israel Institute for Biological Research (IIBR) is beginning Phase 1 human trials. Head of IIBR, Professor Shapira confirmed this at the recent Christian Media zoom Summit attended by this newsletter editor, who asked … Continue reading →